Find the available answers about bumetanide and supplements. Each guide explains its evidence and the forms it covers.
7 published guides. Coverage is limited to the combinations listed.
Glycyrrhizin-containing oral licorice preparations with oral bumetanide tablets. Defined root/stolon preparations are not every processed rhizome, formula or deglycyrrhizinated product.
Read the interaction guide →Oral Panax ginseng products with bumetanide; an older furosemide case involved a germanium-containing mixed exposure.
Read the interaction guide →Magnesium status and replacement during oral bumetanide treatment; healthy short trials differ from long-term illness and PPI co-use.
Read the interaction guide →Oral Herba Taraxaci products with bumetanide. Leaf extract and root-with-herb monograph evidence do not authenticate every aerial-herb preparation.
Read the interaction guide →Oral Equisetum arvense aerial-part products with bumetanide; defined extract evidence is short and healthy-population only.
Read the interaction guide →Oral potassium intake and replacement during oral bumetanide tablets treatment, distinguished from automatic supplementation or intravenous correction.
Read the interaction guide →Oral Juniperus communis preparations with bumetanide; final assessment concerns medicinal cones, not every plant part or essential oil.
Read the interaction guide →A supplement missing from this list has not been cleared for use with the medication. These pages do not assess every product, formulation, or combination.
Publication status, clinical review and change history are shown in each interaction guide.